ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ALPMY Astellas Pharma Inc (PK)

9.51
-0.08 (-0.83%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End March 30 2024 20172018201920202021202220232024
JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)JPY (¥)
Total Revenue 1.31T1.3T1.31T1.31T1.26T1.33T1.52T1.62T
Operating Income 256.49B226.3B267.07B250.2B138.36B147.51B143.15B25.52B
Pre Tax Income 281.77B218.11B248.97B245.35B145.32B156.89B132.36B24.97B
Net Income 218.7B164.68B222.27B195.41B120.59B124.09B98.71B17.05B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 101.54179.6112.265104.95964.77167.5954.5489.419
EBIT 249.9B210.55B228.46B252.15B138.17B147.51B143.15B25.52B
EBITDA 374.18B369.4B377.18B351.55B336.52B330.33B371.29B282.18B

Your Recent History

Delayed Upgrade Clock